Minimed Group, Inc.
MMED
$19.78
$0.281.44%
NASDAQ
| 04/24/2026 | 01/23/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.95% | 7.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.95% | 7.12% | |||
| Cost of Revenue | -15.40% | 32.50% | |||
| Gross Profit | 30.43% | -12.17% | |||
| SG&A Expenses | -3.24% | 7.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -62.50% | 814.29% | |||
| Total Operating Expenses | -12.54% | 20.55% | |||
| Operating Income | 180.46% | -970.00% | |||
| Income Before Tax | 7.07% | -10,000.00% | |||
| Income Tax Expenses | 675.00% | 4.35% | |||
| Earnings from Continuing Operations | -66.67% | -957.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | -100.00% | |||
| Net Income | -55.46% | -720.69% | |||
| EBIT | 180.46% | -970.00% | |||
| EBITDA | 327.08% | -197.96% | |||
| EPS Basic | -46.59% | 30.83% | |||
| Normalized Basic EPS | 167.74% | -- | |||
| EPS Diluted | -47.06% | 30.83% | |||
| Normalized Diluted EPS | 167.74% | -- | |||
| Average Basic Shares Outstanding | 6.05% | -- | |||
| Average Diluted Shares Outstanding | 6.05% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||